Selecta Biosciences, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue of Selecta Biosciences, Inc. on 31/03/2021 amounted to 11 050 000 $. The dynamics of Selecta Biosciences, Inc. net revenue fell by -901 000 $ compared to the previous report. Here are the main financial indicators of Selecta Biosciences, Inc.. The financial graph of Selecta Biosciences, Inc. displays the online status: net income, net revenue, total assets. The financial report chart on our website displays information by dates from 30/06/2018 to 31/03/2021. Information on Selecta Biosciences, Inc. net income on the chart on this page is drawn in blue bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
11 050 000 $
+110 400 % ↑
-24 597 000 $
-
31/12/2020
11 951 000 $
+1 223.480 % ↑
-15 446 000 $
-
30/09/2020
4 646 000 $
-
-9 729 000 $
-
30/06/2020
0 $
-100 % ↓
-24 081 000 $
-
30/09/2019
0 $
-
-11 994 000 $
-
30/06/2019
13 000 $
-
-16 394 000 $
-
31/03/2019
10 000 $
-
-12 074 000 $
-
31/12/2018
903 000 $
-
-14 651 000 $
-
30/09/2018
0 $
-
-16 001 000 $
-
30/06/2018
0 $
-
-18 796 000 $
-
Show:
to
Selecta Biosciences, Inc. financial report charts
The latest dates of Selecta Biosciences, Inc. financial statements available online: 30/06/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Selecta Biosciences, Inc. is 31/03/2021. Gross profit Selecta Biosciences, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Selecta Biosciences, Inc. is -1 954 000 $
Selecta Biosciences, Inc. quarterly report dates
Cost of revenue Selecta Biosciences, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Selecta Biosciences, Inc. is 13 004 000 $ Total revenue Selecta Biosciences, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Selecta Biosciences, Inc. is 11 050 000 $ Operating income Selecta Biosciences, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Selecta Biosciences, Inc. is -7 158 000 $
Net income Selecta Biosciences, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Selecta Biosciences, Inc. is -24 597 000 $ Current assets Selecta Biosciences, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Selecta Biosciences, Inc. is 163 125 000 $ Total assets Selecta Biosciences, Inc. refers to the total amount of assets owned by a person or entity. Total assets Selecta Biosciences, Inc. is 176 746 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-1 954 000 $
-15 859 000 $
-5 062 000 $
-6 762 000 $
-4 230 000 $
-8 452 000 $
-3 193 000 $
-4 589 000 $
-11 885 000 $
-8 998 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
13 004 000 $
27 810 000 $
9 708 000 $
6 762 000 $
4 230 000 $
8 465 000 $
3 203 000 $
5 492 000 $
11 885 000 $
8 998 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
11 050 000 $
11 951 000 $
4 646 000 $
-
-
13 000 $
10 000 $
903 000 $
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
13 000 $
10 000 $
903 000 $
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-7 158 000 $
-7 898 000 $
-13 734 000 $
-16 367 000 $
-11 794 000 $
-16 235 000 $
-11 856 000 $
-14 499 000 $
-15 941 000 $
-18 769 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-24 597 000 $
-15 446 000 $
-9 729 000 $
-24 081 000 $
-11 994 000 $
-16 394 000 $
-12 074 000 $
-14 651 000 $
-16 001 000 $
-18 796 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-12 719 000 $
4 252 000 $
3 968 000 $
3 874 000 $
3 669 000 $
4 150 000 $
4 764 000 $
-
5 409 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
18 208 000 $
19 849 000 $
18 380 000 $
16 367 000 $
11 794 000 $
16 248 000 $
11 866 000 $
15 402 000 $
15 941 000 $
18 769 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
163 125 000 $
151 343 000 $
166 502 000 $
61 052 000 $
36 119 000 $
44 449 000 $
59 528 000 $
42 076 000 $
55 568 000 $
68 835 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
176 746 000 $
165 435 000 $
180 996 000 $
75 206 000 $
39 544 000 $
46 947 000 $
62 482 000 $
44 482 000 $
60 323 000 $
73 437 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
125 407 000 $
138 685 000 $
146 261 000 $
59 730 000 $
279 000 $
30 200 000 $
32 173 000 $
37 403 000 $
50 485 000 $
60 237 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
29 478 000 $
31 908 000 $
33 046 000 $
35 144 000 $
34 632 000 $
13 891 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
44 459 000 $
46 891 000 $
47 663 000 $
49 900 000 $
50 323 000 $
49 175 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
112.43 %
99.88 %
76.28 %
112.18 %
83.42 %
66.96 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-19 571 000 $
-18 006 000 $
-7 382 000 $
-13 052 000 $
-4 915 000 $
56 000 $
14 819 000 $
-5 418 000 $
10 000 000 $
24 262 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-11 122 000 $
-7 197 000 $
-20 240 000 $
-12 748 000 $
-16 031 000 $
-16 973 000 $
Last revenue report of Selecta Biosciences, Inc. was 31/03/2021. According to last financial report total revenue in Selecta Biosciences, Inc. was 11 050 000 US dollar and changed by +110 400% since last year. Net income in Selecta Biosciences, Inc. was -24 597 000 $ in last quartal, net income changes to 0%.
Current cash Selecta Biosciences, Inc. - the sum of all of the cash a company has on the date of report. Current cash Selecta Biosciences, Inc. is 125 407 000 $
Selecta Biosciences, Inc. stocks data
SELB stock price
Selecta Biosciences, Inc. stock price today, SELB stock quote.
